ArticleKidney international reports2022

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

Peter Rossing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.